key: cord-0319157-06tk0z88 authors: Haney, Joanne; Vijayakrishnan, Swetha; Streetley, James; Dee, Kieran; Goldfarb, Daniel Max; Clarke, Mairi; Mullin, Margaret; Carter, Stephen D; Bhella, David; Murcia, Pablo R title: In vitro coinfection by influenza A virus and respiratory syncytial virus generates hybrid viral particles with altered structure and tropism date: 2022-05-12 journal: bioRxiv DOI: 10.1101/2021.08.16.456460 sha: d7632b93387eb61ba922f612d6cd21a83318a893 doc_id: 319157 cord_uid: 06tk0z88 Interactions between respiratory viruses impact viral transmission dynamics and clinical outcomes. To identify and characterize virus-virus interactions at the cellular level, we coinfected human lung cells with influenza A virus (IAV) and respiratory syncytial virus (RSV). Super-resolution microscopy, live-cell imaging, scanning electron microscopy, and cryo-electron tomography revealed extracellular and membrane-associated filamentous structures consistent with hybrid viral particles (HVPs). We show that HVPs harbor surface glycoproteins and ribonucleoproteins of IAV and RSV, and use the RSV fusion glycoprotein to evade anti-IAV neutralising antibodies and to infect and spread among cells lacking IAV receptors. Finally, we show evidence of IAV and RSV coinfection within cells of the bronchial epithelium, with viral proteins from both viruses co-localising at the apical surface. Our observations have profound implications for infection biology as they define a previously unknown interaction between respiratory viruses that might affect virus pathogenesis by expanding virus tropism and facilitating immune evasion. Viruses are intracellular pathogens whose replication relies on the infection of a restricted 32 subset of cell types, a property known as tropism. As multiple viruses exhibit the same tropism, 33 cells and tissues are susceptible to infection by a community of taxonomically diverse viruses. 34 From this perspective, a tissue or body compartment constitutes an ecological niche in which 35 members of a virus community co-exist. Coinfections by more than one virus represent 36 between ~10-30% of all respiratory viral infections and are common among children (1, 2) . 37 The clinical impact of viral coinfections is unclear: while some studies indicate that 38 coinfections do not alter the outcome of disease (3-5), others report increased incidence of viral 39 pneumonia (6, 7). At the cellular level, the underlying interactions that determine the outcome 40 of coinfections are unclear. Direct interactions between viruses within coinfected cells can 41 result in changes to viral progenies, including -but not limited to-pseudotyping (incorporation 42 of surface proteins from a different virus) (8-10) or genomic rearrangements, which may 43 generate novel strains with pandemic potential such as SARS-CoV-2 and pandemic influenza 44 A viruses (11, 12) . Here, we examined interactions between two commonly co-circulating 45 viruses of clinical importance: influenza A virus (IAV) and respiratory syncytial virus (RSV). 46 IAV causes over five million hospitalizations each year (13) and RSV is the leading cause of 47 acute lower respiratory tract infection in children under five years of age (14, 15). 48 To study virus-virus interactions during confection, we infected a cell line derived from human 49 lung (A549) (16), with a mixed inoculum of IAV and RSV, or individual viruses as controls. 50 Infections were performed at high multiplicity of infection (MOI) to facilitate coinfection and 51 recapitulate high MOIs produced in advanced stages of infection (when IAV and RSV foci 52 may come into contact). We compared viral replication in single infections and coinfections. 53 Single IAV infections resulted in robust replication, peaking between 24-48 hours post-54 infection (hpi). In coinfections, IAV replication was similar to that observed in coinfection or 55 at some timepoints marginally increased (Fig. 1a, top left) . As RSV titres peaked in single 56 infections at a later timepoint than IAV (72 hpi, Fig. 1a , top right), further infections were 57 performed to determine optimal conditions for coinfections by using a reduced IAV MOI (ten-58 fold reduction relative to RSV). The reduced IAV input did not affect IAV replication, which 59 still replicated to higher titres in coinfections (Fig. 1a, bottom left) . In contrast, RSV titres were 60 significantly reduced, by over 400-fold at 72 hpi, in the presence of IAV both at equivalent 61 MOI (Fig. 1a , top right) and when IAV MOI was reduced relative to RSV (Fig. 1a, bottom 62 right). These results are consistent with published studies that show that RSV is adversely 63 impacted by coinfection, while IAV replication is not (17, 18) . 64 To assess if coinfection affected localization of key viral proteins or the proportion of infected 65 cells, single and coinfections were performed as described above and cells were fixed at 24 66 hpi. Immunofluorescence microscopy revealed that cells infected with either RSV or IAV 67 displayed features typical of the replicative cycle of each virus, such as cytoplasmic inclusion 68 bodies containing RSV nucleoprotein (N), or diffuse IAV nucleoprotein (NP) staining within 69 the cytoplasm (Fig. 1b, left column) . Similar features were observed in coinfected cells (Fig. 70 1b, boxed area) suggesting that coinfection did not affect the intracellular localization of viral 71 proteins. We counted the number of infected cells in single infections alongside the number of 72 single infected and coinfected cells in the coinfection condition. We observed a high proportion 73 of coinfected cells at 24 hpi when cells were infected with equivalent amounts of virus as well 74 as when IAV input MOI was reduced 10-fold relative to RSV (Fig. 1c) , suggesting that 75 superinfection exclusion does not prevent coinfection. Paradoxically, a higher number of RSV-76 positive cells were detected in coinfections than in RSV single-infected samples, contrasting 77 with the observed reduction in RSV titre in coinfections. IAV and RSV are enveloped viruses that target lipid rafts for assembly and budding (19, 20) . 79 We therefore stained cells for the major glycoproteins of IAV and RSV: hemagglutinin (HA) In coinfected cells, HA was not excluded from RSV budding sites (Fig. 1b , right column, boxed 85 area). We thus hypothesized that mixing of glycoproteins within these regions may result in 86 incorporation of both IAV and RSV components to budding viral particles. To test this, we 87 applied super-resolution confocal microscopy to image virions immunolabelled for HA and F 88 at high resolution. We observed dual-positive fluorescence suggesting the presence of budding 89 viral filaments possessing both IAV and RSV glycoproteins during coinfection (Fig. 2a, b) . 90 Strikingly, minimal colocalization between the two glycoproteins was observed. Instead, 91 glycoproteins were incorporated in distinct regions along the filament, with most dual-positive 92 filaments positive for IAV HA at the distal end (Extended Data Fig. 1 ). 56±9.1% (mean ± SD) 93 of coinfected cells displayed cell-associated dual-positive filaments. Many of these cells 94 showed extensive production of dual-positive filaments, with no obvious indication of cell 95 damage (Fig. 2c, d) . We also observed dual-positive filaments distant from coinfected cells, 96 suggesting they remained intact upon budding (Fig. 2b) . Nested among dual-positive filaments 97 (both cell-associated and released), we identified filaments corresponding to IAV and RSV 98 virions (identified by HA or F only staining) (Fig. 2a, b, Extended Data Fig. 1 ). This indicates that regions in which dual-positive filaments form may contain both IAV and RSV budding 100 sites. 101 We performed microscopy on live cells to visualize the native organization of the filaments 102 budding from coinfected cells. Consistent with our previous observations, we detected bundles 103 of filaments protruding from the cell surface that incorporated F along the length of the filament 104 with HA localized at the distal end (Fig. 2e) . To obtain better resolution of these budding IAV and RSV regions but were absent from the membrane bridging the two regions (Fig. 3f) . 129 We also identified virions consistent with RSV filaments containing (containing RSV RNPs) 130 that had a different glycoprotein ordering than expected (Extended data Fig. 3) . The 131 glycoproteins differed in shape when compared to those present on RSV virions and had a 132 triangular arrangement which resembled IAV glycoproteins (Extended data fig. 3c ), rather than 133 ring shaped density more consistent with RSV glycoproteins (Extended data fig. 3e ). They also 134 lacked the long-range helical ordering typical of RSV glycoproteins (Extended data fig.3c and 135 e) (23). We designated these structures pseudotyped viruses (Extended Data Fig. 3a , c and d, 136 Movie 3). Some HVPs with distinct IAV-and RSV-like structural regions also exhibited 137 pseudotyping within the RSV region (Extended Data Fig. 4a-b) . Notably, we did not observe 138 IAV virions or IAV-like regions in hybrid particles that were pseudotyped with RSV 139 glycoproteins. To quantify differences in glycoprotein arrangement, we determined the inter- of IAV was neutralized, suggesting that two-thirds of IAV within this fraction was able to 158 evade antibody-mediated neutralization (Fig. 4a) . In an analogous experiment, we compared 159 the neutralization efficiency of anti-RSV F antibodies (Palivizumab) against viruses collected 160 from cells infected with RSV alone or coinfected. RSV harvested from both single and mixed 161 infections was efficiently neutralized (Fig. 4b) . This suggests that, in contrast to IAV, RSV (Fig. 5d ). This suggests that there is a population of IAV that is dependent on RSV F to gain entry to cells, which in turn suggests that RSV F is the functional glycoprotein of IAV/RSV To determine the potential for HVP formation in a more biologically relevant system, we 223 coinfected differentiated primary human bronchial epithelial cells (HBECs). We observed no 224 difference in IAV replication kinetics between single-infected and coinfected cultures (Fig. 7a) . In coinfections, RSV titres were variable, but the average titres over experimental replicates 226 were lower than in single infections (Fig. 7b) . Trends in replication kinetics between single and Sections were mounted into humid chambers for immunostaining. Sections were permeablised 396 with 1% triton X100 for 10 minutes, followed by three washes with PBS. Sections were 397 blocked with 2% BSA in PBS for 30 minutes at room temperature. Primary antibodies were 398 diluted in 2% BSA solution and applied to sections for two hours at room temperature, followed 399 by washing with PBS. Secondary antibodies were diluted in 2% BSA solution and applied to 400 sections for 1 hour in the dark at room temperature, followed washing with PBS and d.H2O. Slides were mounted with Prolong Gold mounting media containing DAPI (Invitrogen, 402 P36392). Confocal microscopy was carried out using Zeiss LSM880 AxioObserver microscope (ZEISS, 404 Germany). Standard images were collected using GaAsP detector with 405nm, 488nm and 405 598nm excitation lasers, using 40x/1.4 or 63x/1.4 plan-apochromat oil DIC M27 objectives. For the 50,000x magnification tilt-series movie frames were aligned using MotionCor2 with 6 449 by 6 patches (48). Once tilt-series sub-frames were aligned and binned eightfold into 1 k × 1 k 450 arrays they were reconstructed into 3D tomograms using weighted back projection with IMOD. To aid interpretation and visualization, noise reduction was applied using Topaz (49). Figures 452 and supplemental videos were prepared using IMOD, Illustrator ImageJ and Quicktime. Segmentation and isosurface rendering were performed manually using the thresholding tool 454 in Amira (Thermo Fisher Scientific, USA). Glycoprotein-distance was measured and calculated using the imodinfo module in IMOD. Denoised tomograms were averaged between 5-10 slices to improve contrast and glycoproteins incubated for 12 hours. Virus harvested from coinfection was also incubated with 10 µg/well Palivizumab for 1 hour at 37˚c, before transfer to NA-treated or untreated control wells and 498 incubated for 12 hours. Cells were fixed and 96-well plates stained for IAV or RSV Extensive multiplex PCR diagnostics reveal new insights into the 524 epidemiology of viral respiratory infections Correlation of viral load of respiratory pathogens and co-infections with disease 526 severity in children hospitalized for lower respiratory tract infection Single and multiple respiratory virus 529 infections and severity of respiratory disease: a systematic review Respiratory viral coinfection and disease severity in children: A systematic 532 review and meta-analysis Clinical disease severity of respiratory viral co-infection versus single viral 534 infection: a systematic review and meta-analysis Is virus coinfection a predictor of 536 severity in children with viral respiratory infections? Clinical characteristics and outcomes in hospitalized patients with 539 respiratory viral co-infection during the 2009 H1N1 influenza pandemic The pseudotypic paradox Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus High-efficiency gene transfer into CD34+ cells with a human 545 immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis 546 virus envelope glycoprotein G Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for 548 the COVID-19 pandemic Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza 550 A epidemic Global burden of influenza-associated lower respiratory tract infections and 552 hospitalizations among adults: A systematic review and meta-analysis Global burden of acute lower respiratory infections due to respiratory syncytial 555 virus in young children: a systematic review and meta-analysis Global, regional, and national disease burden estimates of acute lower respiratory 558 infections due to respiratory syncytial virus in young children in 2015: a systematic review and 559 modelling study Interferon-beta induces a long-lasting antiviral state in human 561 respiratory epithelial cells Influenza A Virus Inhibits RSV Infection via a Two-Wave Expression of IFIT 563 Proteins Exacerbation of Influenza A 565 Virus Disease Severity by Respiratory Syncytial Virus Co-Infection in a Mouse Model Influenza virus assembly and budding Role of plasma membrane lipid microdomains in respiratory 569 syncytial virus filament formation Cryotomography of budding influenza A virus reveals filaments with 571 diverse morphologies that mostly do not bear a genome at their distal end The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-574 Electron Tomography Helical ordering of envelope-associated proteins and glycoproteins in 576 respiratory syncytial virus Human rhinovirus infection blocks SARS-CoV-2 replication within the respiratory 578 epithelium: implications for COVID-19 epidemiology Virus-virus interactions impact the population dynamics of influenza and 580 the common cold Interference between rhinovirus and 582 influenza A virus: a clinical data analysis and experimental infection study Dynamic innate immune response determines susceptibility to SARS-585 CoV-2 infection and early replication kinetics Prevalence of co-infection between 587 respiratory syncytial virus and influenza in children The histopathology of fatal 590 untreated human respiratory syncytial virus infection Pathology of human influenza revisited Sociovirology: Conflict, Cooperation, and 594 Communication among Viruses Tropism, replication competence, and innate immune responses of influenza 596 virus: an analysis of human airway organoids and ex-vivo bronchus cultures Respiratory syncytial virus 599 infection of human airway epithelial cells is polarized, specific to ciliated cells, and without 600 obvious cytopathology Influenza virus budding from the tips of cellular microvilli in differentiated 602 human airway epithelial cells Mathematical model of influenza A virus production 604 in large-scale microcarrier culture The Rab11 pathway is required for influenza A virus budding 606 and filament formation Respiratory syncytial virus uses a Vps4-independent budding mechanism 608 controlled by Rab11-FIP2 Assembly and budding of negative-strand RNA viruses Structural Analysis of the Roles of Influenza A Virus Membrane-Associated 612 Proteins in Assembly and Morphology Structural analysis of respiratory syncytial virus reveals the position of M2-1 614 between the matrix protein and the ribonucleoprotein complex The role of viral co-infections in the severity of acute 616 respiratory infections among children infected with respiratory syncytial virus (RSV): A 617 systematic review and meta-analysis Respiratory Syncytial Virus Coinfections With Rhinovirus and Human Bocavirus 619 in Hospitalized Children Respiratory syncytial virus: co-infection and paediatric lower respiratory 621 tract infections Viral pneumonia Asparagine 631 variants of the chicken Mx 625 protein do not inhibit influenza virus replication in primary chicken embryo fibroblasts or in 626 vitro surrogate assays Computer visualization of three-dimensional 628 image data using IMOD Automated electron microscope tomography using robust prediction of 630 specimen movements MotionCor2: anisotropic correction of beam-induced motion for improved 632 cryo-electron microscopy Topaz-Denoise: general deep denoising models for 634 cryoEM and cryoET R: A language and environment for statistical computing Elegant graphics for data analysis Structural organization of a 638 filamentous influenza A virus Significant differences in nucleocapsid morphology 640 within the Paramyxoviridae Representative tomograms of the chimeric virus particles described in this paper have been 643 deposited in the Electron Microscopy Data Bank (www.ebi.ac.uk/emdb) under accession codes Author contributions 647 Investigation, Methodology, Formal analysis, Visualisation 648 Investigation, Data curation, Formal analysis, Resources, Metodology, Validation Visualisation, Supervision Writing-original draft Investigation, Writing -review and 650 editing Investigation, Writing -review and editing Investigation, Writing -651 review and editing Investigation, Writing -review and editing Writing -review and editing; S.D.C: Formal analysis, writing, review and 653 editing Resources, Funding acquisition, Writing -review and editing Validation, Data curation, Supervision, Funding acquisition, 655 Project administration, Writing -original draft This work was supported by grants from the Medical Research Council of the United Kingdom The Scottish Centre for 660 Macromolecular Imaging (SCMI) is funded by the MRC (MC_PC_17135) and SFC (H17007) Conflicts of interest. The authors declare no conflicts of interest Correspondence and requests for materials should be addressed to Pablo Murcia Coinfection of primary differentiated human bronchial epithelial cell cultures 764 (hBECs) results in robust replication of IAV and RSV, with evidence of cellular 765 coinfection. (a) IAV replication kinetics in hBEC cultures in single infection (magenta bars) 766 and mixed infection with RSV (teal bars), n=6 individual transwells over 3 independent 767 experiments. (b) RSV replication kinetics in hBEC cultures in single infection (green bars) and 768 mixed infection with RSV (dark blue bars). n=6 individual transwells over three independent 769 experiments. (c) Paraffin embedded sections collected at 24 hpi, stained with haemotoxylin 770 and eosin Coinfected section imaged by super-772 resolution confocal microscopy shows localisation of IAV HA (magenta) and RSV antigen 773 (green) to the apical surface of epithelial cells. Scale bar represents 20 µm. The magnified area 774 (i) shows the region indicated by the white dashed box, highlighting a coinfected cell with IAV 775 HA and RSV antigen localised at apical surface (blue arrow). (f) Localisation of IAV NP 776 (magenta) and RSV antigen (green) within coinfected cells. Scale bar represents 20 µm. The 777 magnified area (ii) shows the region indicated by the white dashed box highlighting IAV NP 778 and RSV antigen within the cytoplasm, where RSV inclusion bodies can be observed Movie 1: Video showing serial sections through the z-axis of a tomogram of a hybrid particle 781 with a multiple IAV region, formed during coinfection of IAV and RSV (corresponding image 782 shown in Fig. 3). Glycoproteins and RNPs of both IAV and RSV are labeled and denoted by 783 arrows Movie 2: Video showing serial sections through the z-axis of a tomogram of hybrid particle 785 with IAV and RSV regions with an adjoining region with a clear lumen (corresponding image 786 shown in Extended data Fig. 4C). Glycoproteins and RNPs of both IAV and RSV are labeled 787 and denoted by arrows Movie 3: Video showing serial sections through a tomogram of a pseudotyped viral filament 789 generated during IAV and RSV coinfection (corresponding image shown in Extended data Fig Glycoproteins and RNPs are labeled and denoted by arrows 874 We identified structures consistent with IAV filaments and pleiomorphic particles that were 875 densely coated with glycoproteins (Fig. 1A, Video S1 ). IAV filaments varied in length, with (Figs. 1C and 1D ). RNPs could be clearly seen in many IAV and RSV filaments. While IAV comprised a single ordered set of RNPs in a "7+1" arrangement at the distal end of 884 filaments, multiple RNPs were detected within RSV filaments having herringbone morphology 885 and ring-like structures attributed to be nucleocapsid (N) or N-RNA assemblies (23, 52, 53) 886 ( Fig. 1A-D, Fig. 2) . Upon closer inspection of glycoproteins on the surface of virions (top and 887 bottom slices in the tomograms), distinct patterns of glycoprotein arrangement were observed 888 between the two viruses. In IAV virions, glycoproteins were densely packed, devoid of any 889 long-range order, with the "triangular-shaped" trimeric head of HA clearly visible (Fig. 1E, 1F , 890 Fig. 3) . However, RSV exhibited a more symmetrical helical arrangement of glycoproteins 891 (striped layers of density) with specific clustering in pairs (Fig. 1G, 1H, Fig. 3 ).